UBS O'Connor’s Day One Biopharmaceuticals DAWN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $697K | Sell |
107,249
-6,001
| -5% | -$39K | 0.04% | 231 |
|
|
2025
Q1 | $898K | Buy |
113,250
+63,230
| +126% | +$501K | 0.03% | 181 |
|
|
2024
Q4 | $634K | Buy |
+50,020
| New | +$634K | 0.02% | 255 |
|
|
2023
Q2 | – | Sell |
-28,053
| Closed | -$375K | – | 540 |
|
|
2023
Q1 | $375K | Buy |
+28,053
| New | +$375K | 0.01% | 469 |
|
|
2022
Q4 | – | Sell |
-37,000
| Closed | -$741K | – | 82 |
|
|
2022
Q3 | $741K | Buy |
+37,000
| New | +$741K | 0.01% | 761 |
|